Insider plans Cognex (CGNX) Rule 144 resale of common stock via broker

Rhea-AI Filing Summary

An affiliate of Cognex (CGNX) filed a notice of proposed resale of Cognex common stock under Rule 144. The notice covers planned sales of 2,381 shares and 12,500 shares through Robert W. Baird & Co., with aggregate market values of $134,670.00 and $715,884.00 on the NASDAQ. Cognex had 165,707,920 shares outstanding at the time referenced. The securities to be sold were acquired primarily through RSU releases in 2024 and 2025 and the cash exercise of a stock option originally granted in 2017.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Robert W Baird & Co 777 East Wisconsin Avenue Milwaukee WI 53202	2381	134670.00	165707920	02/12/2026	NASDAQ
Common Stock	Robert W Baird & Co 777 East Wisconsin Avenue Milwaukee WI 53202	12500	715884.00	165707920	02/12/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/16/2024	RSU Release	Issuer			833	02/16/2024	Settlement of vested Restricted Stock Unit award
Common Stock	02/21/2024	RSU Release	Issuer			720	02/21/2024	Settlement of vested Restricted Stock Unit award
Common Stock	02/20/2025	RSU Release	Issuer			828	02/20/2025	Settlement of vested Restricted Stock Unit award
Common Stock	02/12/2026	Option Granted - 02/21/2017	Issuer			12500	02/12/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filing for CGNX disclose?

The Form 144 filing discloses a planned resale of Cognex (CGNX) common stock by an affiliate under Rule 144. It details the number of shares, aggregate market values, acquisition methods, and use of Robert W. Baird & Co. as broker.

How many Cognex (CGNX) shares are covered by this Form 144?

The notice covers proposed sales of 2,381 shares and 12,500 shares of Cognex common stock. Each line item includes its own aggregate market value and references NASDAQ as the exchange where the stock is traded.

What are the aggregate market values of the CGNX shares to be sold?

The planned sales have aggregate market values of $134,670.00 for 2,381 shares and $715,884.00 for 12,500 shares. These figures reflect the filer’s estimate of the market value at the time of the notice.

How were the Cognex (CGNX) shares in this Form 144 acquired?

The shares were acquired mainly through RSU releases in 2024 and 2025, plus an option exercise originally granted on 02/21/2017. RSU awards were settled in stock, while the option exercise was paid in cash.

Which broker will handle the CGNX stock sales in this Form 144?

The planned Cognex stock sales will be handled by Robert W. Baird & Co., located at 777 East Wisconsin Avenue, Milwaukee, WI 53202. The filing lists NASDAQ as the securities exchange for these transactions.

How many Cognex (CGNX) shares were outstanding in this Form 144?

The Form 144 lists 165,707,920 shares of Cognex common stock as outstanding. This figure provides a baseline share count for context relative to the proposed Rule 144 sales described in the notice.